GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.50
Ask: 41.50
Change: -1.40 (-3.30%)
Spread: 1.00 (2.469%)
Open: 41.50
High: 41.50
Low: 40.50
Prev. Close: 42.40
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down

Thu, 25th Mar 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Ten Entertainment Group PLC - Cranfield, England-based tenpin bowling operator - Nick Basing will step down as chair in September, after 6 years in the role and 12 with the company and its predecessor Essenden. Company has started the process of finding a replacement.

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Mark Connelly retires as non-executive chair at general meeting, during which shareholders also approved Emmerson's move to AIM from the London Main Market, effective from Friday. Non-Executive Director James Kelly is promoted to independent non-executive chair.

----------

Ceres Power Holdings PLC - Horsham, West Sussex-based solid oxide fuel cell developer - Hires Tudor Brown as independent non-executive director, starting Thursday next week. Brown was among the founders of computer chip designer ARM Holdings PLC and served ARM as chief technology officer and chief operating officer. He is on the board of Hong Kong-listed personal computer and smart phone maker Lenovo Group Ltd.

----------

Atalaya Mining PLC - copper and silver mining in Spain - Jose Sierra will retire as an independent non-executive director on Wednesday next week, having served on the Atalaya board since 2011.

----------

Euromoney Institutional Investor PLC - London-based business media and events - Lorna Tilbian steps down as non-executive director, effective immediately, "to spend more time focusing on her other business interests".

----------

Biome Technologies PLC - Southampton, Hampshire-based biodegradable plastics and radio frequency systems - Hires Simon Herrick as non-executive director, joining immediately. Herrick is a non-executive director of London listings Ramsdens Holdings PLC and FireAngel Safety Technology Group PLC. As an executive, Herrick was chief financial officer for a number of companies, including department store chain Debenhams and Blancco Technology Group PLC. He will replace Michael Kayser as chair of the audit and remuneration committees when Kayser retires from the board at the Biome's annual general meeting on April 21.

----------

Avacta Group PLC - Wetherby, England-based developer of cancer immunotherapies - Mike Owen steps down as non-executive director, effective immediately, but remains chair of Avacta's scientific advisory board.

----------

Arrow Global Group PLC - European investor and alternative asset manager of loan portfolios - Appoints Davide Stecchi as managing director of Underwriting to lead the Arrow Capital Management underwriting team. Prior to joining Arrow, Stecchi spent 7 years at Hudson Advisors.

----------

Tirupati Graphite PLC - London-based graphite producer with operations in Madagascar and India - Strengthens its team across its three business units to support its growth. Appoints Biswal as head of the Tirupati Graphene & Mintech Research Centre. Names Sathpathy as an advisor to the company, specially focussed on application of graphene in aluminium manufacturing smelters and graphene aluminium composites development. Appoints Dash, who is also focused on graphene engineering science, to board.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Apr 2019 12:11

Avacta falls as stuttering revenues exacerbate losses

(Sharecast News) - Avacta Group's shares slid on Tuesday as interim revenues dropped on the back of a lower contribution from the life sciences division, which resulted in wider losses.

Read more
9 Apr 2019 10:37

Avacta shares fall as interim revenues slide

(Sharecast News) - Biotherapeutics and research reagents developer Avacta Group reported a fall in half-year revenues to £1.0m on Tuesday, from £1.5m a year earlier.

Read more
9 Apr 2019 09:49

Avacta Shares Fall On Widened Interim Loss, Lower Revenue

LONDON (Alliance News) - Avacta Group PLC on Tuesday reported a widened first half loss mainly due to lower income contribution from life sciences unit.The stock was trading 8.5% lower on a

Read more
28 Jan 2019 12:01

Avacta Hires IP Group Unit Boss Sam Williams As Non-Executive Director

LONDON (Alliance News) - Avacta Group PLC on Monday said it has appointed Sam Williams as a non-executive director with immediate effect.The biotechnology company said Williams is currently

Read more
21 Jan 2019 12:14

Avacta Group makes solid development progress

(Sharecast News) - Biotherapeutics developer Avacta Group updated the market on its trading on Monday, as investors gathered for its annual general meeting.

Read more
3 Jan 2019 11:34

IP Group Builds Over 17% Holding In Biotechnology Firm Avacta (ALLISS)

LONDON (Alliance News) - Avacta Group PLC on Thursday said IP Group PLC now holds 17.2% stake in the biotechnology company following a transaction on December 18.Prior to that, IP holding

Read more
12 Dec 2018 11:14

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer

LONDON (Alliance News) - Reagents developer Avacta Group PLC on Wednesday appointed Jose Saro as chief medical officer to lead the firm's therapeutic development strategy.Saro brings 20

Read more
12 Dec 2018 09:45

Avacta Group picks up Jose Saro as chief medical officer

(Sharecast News) - Biotherapeutic development company Avacta Group announced on Wednesday that Dr Jose Saro has been appointed as its chief medical officer, to lead its therapeutic development strategy and drive the in-house programmes into the clinic.

Read more
10 Dec 2018 08:52

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate

LONDON (Alliance News) - IP Group PLC on Monday said its portfolio company Avacta Group PLC signed a development & license deal with LG Chem Life Sciences.IP Group currently holds a in

Read more
10 Oct 2018 16:33

Avacta 'delighted' at license agreement with longtime collaborator

(Sharecast News) - Avacta Group agreed a commercial license with New England Biolabs (NEB) to commercialise a science and research assay project using its Affimer technology on Wednesday.

Read more
2 Oct 2018 15:23

Avacta hails progress on in-house and third-party programmes

(Sharecast News) - Avacta Group posted a slightly wider full-year loss on Wednesday even as it highlighted progress both with its in-house programmes and third parties.

Read more
2 Oct 2018 09:42

Avacta Annual Revenue Increases But Loss Widens On Higher Expenses

LONDON (Alliance News) - Avacta Group PLC on Tuesday said its loss widened in its recently-ended financial year on higher costs, as it continues to progress Affimer.The reagents developer a

Read more
23 Aug 2018 17:38

FIL Reduces Avacta Stake To Below 5% Threshold After Deal (ALLISS)

LONDON (Alliance News) - Avacta Group PLC said Thursday that FIL Ltd decreased its stake in the biotechnology company to below 5% after a transaction on Tuesday.FIL lowered its holding to a

Read more
23 Aug 2018 14:20

Lombard Odier Asset Management Lowers Holding In Avacta (ALLISS)

LONDON (Alliance News) - Avacta Group PLC on Thursday said Lombard Odier Asset Management Europe Ltd reduced its holding in the biotechnology company.In a transaction on Tuesday, Lombard to

Read more
30 Jul 2018 18:17

UPDATE: Avacta Raises GBP12 Million To Fund New Drug Development (ALLISS)

LONDON (Alliance News) - Biotherapeutics firm Avacta Group PLC late Monday said it raised GBP11.6 million before expenses to help fund new drug development partnerships.Early on Monday, to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.